BLOCK 9          Click on below LINKS to see the Required Readings (Please Read before Roundings)

 

MONDAY

TUESDAY

WEDNESDAY

THURSDAY

FRIDAY

3/1/21

 

No lecture

 

3/2/21

 

Atrial Fibrillation -

And other cardiac arrhythmias*

Orange Team - Primary Rounder

 

3/3/21

 

Acute Asthma*

 

Blue Team - RIC

3/4/21

 

Diabetic Emergencies*

 

Blue Team - Primary Rounder

 

3/5/21

 

Simulation 6:00am -

Dr. Waxman

 

3/8/21

 

No lecture

3/9/21

 

End of Life Care and Hospice*

 

Orange Team - Primary Rounder

 

3/10/21

 

Diarrhea-C difficile*

 

Orange Team - RIC

3/11/21

 

Alcohol and Drug Withdrawal*

 

Blue Team - Primary Rounder

3/12/21

 

Simulation 6:00am -

Dr. Waxman

3/15/21

 

No lecture

3/16/21

 

Complications of End Stage Liver Disease*

 

 Orange Team - Primary Rounder

 

3/17/21

 

UTI’s and Pyelonephritis*

 

Blue Team - RIC

3/18/21

 

Hypertensive Urgency/Emergency*

 

Blue Team - Primary Rounder

3/19/21

 

Simulation 6:00am -

Dr. Waxman

 

M&M-noon to 1pm

 

3/22/21

 

No lecture

3/23/21

 

Pharmacology-Anticoagulation* 

 

C. Tafoya, PharmD

 

3/24/21

 

Acute Gallbladder Disease*

 

Blue Team - Primary Rounder

3/25/21

 

LO 3 Inpatient Medicine Jeopardy

 

Orange and Blue Team RICS

3/26/21

 

Simulation 6:00am -

Dr. Waxman

 

 

LO3 ( Updated 3/1/2021 )

 


1) Acute Asthma (LO3) : (updated 1/9/21)
    a) American Family Physician - “Management of Acute Asthma Exacerbations” July 1, 2011;

        http://www.aafp.org/afp/2011/0701/p40.pdf
        “Medications for Chronic Asthma” September 15, 2016;
        https://www.aafp.org/afp/2016/0915/afp20160915p454.pdf
        FPIN’s Clinical Inquiries “Intravenous Magnesium Sulfate for Acute Asthma Exacerbations” January 15, 2019;
        https://www.aafp.org/afp/2019/0115/p127.pdf
        “More Evidence Against Antibiotics for Acute Asthma Exacerbations” August 1, 2019
        https://www.aafp.org/afp/2019/0801/afp20190801p185.pdf
    b) UpToDate - “Acute exacerbations of asthma in adults: Emergency department and inpatient management”
(REQUIRED READING)
        https://www.uptodate.com/contents/acute-exacerbations-of-asthma-in-adults-emergency-department-and-inpatient-management?search=acute%
       

        20asthma&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2#H304289086
    c) New England Journal of Medicine - “Severe and Difficult-to-Treat Asthma in Adults” September 7, 2017;
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1608969
        “Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations” March 8, 2018
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa1714257?articleTools=true

2) Acute Gallbladder Disease (LO3) :
(updated 1/16/21)
    a) American Family Physician - “Surgical and Non-Surgical Management of Gallstones” May 15, 2014:
        http://www.aafp.org/afp/2014/0515/p795.pdf
(REQUIRED READING)
    b) New England Journal of Medicine - “Acute Calculous Cholecystitis” - June 26, 2008
        http://www.nejm.org/doi/pdf/10.1056/NEJMcp0800929
        “ERCP for Gallstone Pancreatitis” January 9, 2014:
        http://www.nejm.org/doi/pdf/10.1056/NEJMct1208450
    c) Up-To-Date - “Uncomplicated Gallstone Disease in Adults”;
        http://www.uptodate.com/contents/uncomplicated-gallstone-disease-in-adults?search=gallbladder+disease&source=search_result&selectedTitle=1~150
       
“Acute Cholecystitis: Pathogenesis, Clinical Features and Diagnosis”;
        http://www.uptodate.com/contents/acute-cholecystitis-pathogenesis-clinical-features-and-diagnosis?search=gallbladder+disease&source=search_result&selectedTitle=2%7E150
        “Treatment of acute calculous cholecystitis”-
        https://www.uptodate.com/contents/treatment-of-acute-calculous-cholecystitis
?

        search=cholecystitis&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2

3) Alcohol and Drug Withdrawal (LO3) :
(updated 1/16/21)
    a) American Family Physician - “Outpatient Management of Alcohol Withdrawal Syndrome” - November 1, 2013;
        http://www.aafp.org/afp/2013/1101/p589.pdf
    b) New England Journal of Medicine - “Recognition and Management of Withdrawal Delirium (Delirium Tremens)” - November 27, 2014
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1407298
        “Electrolyte Disturbances in Patients with Chronic Alcohol-Use Disorder” - October 5, 2017;
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1704724
        “Buproprion and Naltrexone in Methamphetamine Use Disorder - January 14, 2021
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa2020214?articleTools=true
    c) UpToDate - “Management of Moderate and Severe Alcohol Withdrawal Syndromes” -
        http://www.uptodate.com/contents/management-of-moderate-and-severe-alcohol-withdrawal-syndromes?source=search_result&search=alcohol+withdrawal&selectedTitle=1~130   

        (REQUIRED READING)

4) Atrial Fibrillation and other cardiac arrhythmias (LO3) :
(1/16/21)
    a) American Family Physician - “Diagnosis and Management of Common Types of Supraventricular Tachycardia” November 1, 2015
        https://www.aafp.org/afp/2015/1101/p793.pdf

        “Diagnosis and Treatment of Atrial Fibrillation” September 13, 2016
        http://www.aafp.org/afp/2016/0915/p442.pdf
        Cochran for Clinicians: “Direct Oral Anticoagulants vs. Warfarin to Prevent Stroke and Embolic Events in Patients with Atrial Fibrillation and CKD” April 1, 2019
        https://www.aafp.org/afp/2019/0401/p422.pdf
        Cochrane for Clinicians: “Effectiveness and Safety of Factor Xa Inhibitors in Patients with Atrial Fibrillation” October 1, 2019
        https://www.aafp.org/afp/2019/1001/p405.pdf
    b) Journal of the American College of Cardiology - “2019 AHA/ACC/HRS Focused Update of the 2014

        Guideline for the Management of Patients with Atrial Fibrillation” (REQUIRED READING)

        https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2019/2019-Afib-Guidelines-Made-Simple-Tool.pdf
    c) New England Journal of Medicine - “Catheter Ablation for Atrial Fibrillation with Heart Failure” February 1, 2018
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa1707855?articleTools=true
        “Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease” September 19, 2019

        https://www.nejm.org/doi/pdf/10.1056/NEJMoa1904143?articleTools=true
        “Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation” April 18, 2019
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa1817083?articleTools=true
        “Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation - April 18, 2019
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa1900353?articleTools=true
        “Alcohol Abstinence in Drinkers with Atrial Fibrillation” January 2, 2020
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa1817591?articleTools=true
        “Early Rhythm-Control Therapy in Patients with Atrial Fibrillation”- October 1, 2020
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa2019422?articleTools=true
        “Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation”- November 16, 2020
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa2029980?articleTools=true

5) Complications of End Stage Liver Disease (LO3) :
(updated 1/17/21)
    a) American Family Physician - “Antibiotic Prophylaxis in Patients with Cirrhosis and Upper Gastrointestinal Bleeding” May 1, 2017
        https://www.aafp.org/afp/2017/0501/p582.pdf
        “Cirrhosis: Diagnosis and Management” December 15, 2019
        https://www.aafp.org/afp/2019/1215/p759.pdf
    b) New England Journal of Medicine - “Rifaximin in the Treatment of Hepatic Encephalopathy” March 25, 2010;
        http://www.nejm.org/doi/pdf/10.1056/NEJMoa0907893
        “Treatment of Patients with Cirrhosis” August 25, 2016
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1504367
        “Hepatic Encephalopathy” October 27, 2016
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1600561
        “Acute on Chronic Liver Failure”- May 28, 2020
        https://www.nejm.org/doi/pdf/10.1056/NEJMra1914900?articleTools=true
    c) UptoDate - “Acute liver failure in adults: Management and prognosis”-
(RECOMMENDED READING)
        https://www.uptodate.com/contents/acute-liver-failure-in-adults-management-and-prognosis?search=acute%20liver%

        20failure&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2


6) Diabetic Emergencies-DKA and HHS (LO3) :
(updated 1/17/21)
    a) American Family Physician - “Diabetic Ketoacidosis: Evaluation and Treatment”- March 1, 2013
(REQUIRED READING)  
        http://www.aafp.org/afp/2013/0301/p337.pdf
        “Hyperglycemic Hyperosmolar State”- December 1, 2017
(REQUIRED READING)
        https://www.aafp.org/afp/2017/1201/afp20171201p729.pdf
    b) New England Journal of Medicine - “Electrolyte and Acid Base Disturbances in Patients with Diabetes Mellitus” August 6, 2015
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1503102
    c) Up-to-Date - “Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Treatment”
        https://www.uptodate.com/contents/diabetic-ketoacidosis-and-hyperosmolar-hyperglycemic-state-in-adults-treatment?search=diabetic%

        20ketoacidosis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

7) Diarrhea-and C difficile: (LO3)
(updated 1/17/21)
    a) American Family Physician - “Acute Diarrhea in Adults”- February 1, 2014

        http://www.aafp.org/afp/2014/0201/p180.pdf
        “Infectious Diarrhea: ISDA Updates Guidelines for Diagnosis and Management” May 15, 2018
        https://www.aafp.org/afp/2018/0515/p676.pdf
        “Clostridioides difficile Infection” Update on Management” February 1, 2020-
        https://www.aafp.org/afp/2020/0201/p168.pdf
        “Chronic Diarrhea in Adults: Evaluation and Differential Diagnosis” April 15, 2020-
        https://www.aafp.org/afp/2020/0415/p472.pdf
    b) New England Journal of Medicine - “Acute Infectious Diarrhea in Immunocompetent Adults” April 17 2014
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1301069
        “Clostridium Difficile Infection” April 16, 2015
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1403772
        “Oral Rehydration Solutions for the Treatment of Acute Watery Diarrhea”- December 1, 2017
        https://www.aafp.org/afp/2017/1201/afp20171201p700.pdf
        “Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes” April 2, 2020-
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa1910215?articleTools=true
    c) UpToDate - “Approach to the adult with acute diarrhea in resource-rich settings”;
(REQUIRED READING)
        https://www.uptodate.com/contents/approach-to-the-adult-with-acute-diarrhea-in-resource-rich-settings?search=diarrhea%

        20adult&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H659511455

8) Hypertensive Emergencies: (LO-3)
(updated 1/17/21)
    a) American Family Physician - “Severe Asymptomatic Hypertension: Evaluation and Treatment” April 15, 2017

        http://www.aafp.org/afp/2017/0415/p492.pdf
        “Common Questions About the Initial Management of Hypertension” February 1, 2015
        http://www.aafp.org/afp/2015/0201/p172.pdf
    b) New England Journal of Medicine -
        “Acute Severe Hypertension” November 7, 2019;
(REQUIRED READING)
        https://www.nejm.org/doi/pdf/10.1056/NEJMcp1901117?articleTools=true
    c) Uptodate - “Evaluation and treatment of hypertensive emergencies in adults”-

        http://www.uptodate.com/contents/treatment-of-specific-hypertensive-emergencies?source=see_link
        “Hypertensive emergencies: Malignant hypertension and hypertensive encephalopathy in adults”-
        http://www.uptodate.com/contents/hypertensive-emergencies-malignant-hypertension-and-hypertensive-encephalopathy-in-adults?source=related_link#H6
    d) JAMA - “2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults:

        Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)”- February 5, 2014
     
  http://jama.jamanetwork.com/article.aspx?articleid=1791497

9) End of Life Care and Hospice (LO3)
(update 1/17/21)
    a) American Family Physician - “The Hospice Referral” May 1, 2014
        http://www.aafp.org/afp/2014/0501/p745.pdf
    b) New England Journal of Medicine - “Palliative Care for the Seriously Ill” August 20, 2015
        http://www.nejm.org/doi/pdf/10.1056/NEJMra1404684
        “Comfort Care for Patients Dying in the Hospital” December 24, 2015
(REQUIRED READING)
        https://www.nejm.org/doi/pdf/10.1056/NEJMra1411746?articleTools=true
    c) “Clinical Practice Guidelines for Quality Palliative Care 4th edition: Care of the Patient Nearing the End of Life” (National Consensus Project) 2018:
        http://nchpc.conferencespot.org/67968-nchpc-1.4266595/t0018-1.4266728/f0018-1.4266729/a072-1.4266741

 

10) Pharmacology-Anticoagulation: (LO3) (updated 2/19/21)
    a) American College of Cardiology (ACC) expert consensus on management of bleeding in patients on oral anticoagulants

        can be found in J Am CollCardiol 2020 Aug 4;76(5):594.

        https://www.jacc.org/doi/pdf/10.1016/j.jacc.2020.04.053
    b) Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism:

        treatment of deep vein thrombosis and pulmonary embolism. Blood Advances. 2020;4(19):4693-4738.  Available at:

        https://doi.org/10.1182/bloodadvances.2020001830
    c) CHEST Guideline and Expert Panel Report “Antithrombotic Therapy for VTE Disease”

        https://doi.org/10.1016/j.chest.2015.11.026
    d) Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients:

        A Statement for Healthcare Professionals from the Neurocritical Care Society, endorsed by the Society for Critical Care Medicine and the American Association.        

        https://higherlogicdownload.s3.amazonaws.com/NEUROCRITICALCARE/b8b3b384-bfb9-42af-bb55-   

        45973d5054a4/UploadedImages/Cook2020_Article_GuidelinesForTheAcuteTreatment.pdf
    e) Journal of the American Heart Association - “Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges” - June 15, 2020
        https://www.ahajournals.org/doi/10.1161/JAHA.120.017559

    f)  Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism:

         prevention and treatment in patients with cancer. Blood Advances. 2021;5(4):927-974. Available at: 

         https://doi.org/10.1182/bloodadvances.2020003442



11) UTI and Pyelonephritis (LO3):
(updated 1/17/21)
    a) American Family Physician - “Dysuria: Evaluation and Differential Diagnosis in Adults” November 1, 2015;
      
 https://www.aafp.org/afp/2015/1101/p778.pdf
        “Acute Pyelonephritis in Adults: Rapid Evidence Review”- August 1, 2020
(REQUIRED READING)
        https://www.aafp.org/afp/2020/0801/afp20200801p173.pdf
    b) New England Journal of Medicine -  “Urinary Tract Infections in Older Men” February 11, 2016
        https://www.nejm.org/doi/pdf/10.1056/NEJMcp1503950?articleTools=true
        “A Program to Prevent Catheter - Associated Urinary Tract Infection in Acute Care” - June 2, 2016
        https://www.nejm.org/doi/pdf/10.1056/NEJMoa1504906?articleTools=true
        “Acute Pyelonephritis in Adults” January 4, 2018
        http://www.nejm.org/doi/pdf/10.1056/NEJMcp1702758
    c) Up-to-Date “Urinary tract infection associated with urethral catheters”;

        http://www.uptodate.com/contents/urinary-tract-infection-associated-with-urethral-catheters?source=search_result&search=urinary+tract+infection&selectedTitle=3~150

12) “LO 3 Hospital Medicine Jeopardy” (LO3) (RICS)